In addition, WHO grade II meningiomas had significantly stronger intensities of staining and greater percentages of Nrf2-positive tumor cells than did WHO grade I meningiomas (p = 1.8 × 10−5, Figure 6). This evidence concerns the gene NFE2L2 and meningioma.